Understanding why you're not losing weight on semaglutide involves examining multiple factors, from medication dosing and timing to lifestyle habits and underlying medical conditions
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Further study showed a higher dose of semaglutide (Wegovy) was very beneficial for weight loss, and its since been approved by the FDA for that purpose. The problem with more patients benefitting from this drug is that the increased demand has led to a shortage
Elevated IgE levels can indicate the presence of allergies, which may be associated with increased histamine release
Traditional evidence-based approaches such as counseling, behavioral support, and FDA-approved nicotine-replacement or prescription cessation aids remain the standard of care
Astrocytes release ApoE-containing exosomes to transport keto bodies, cholesterol, and phospholipids between glia and neurons to supply them with energy